… known to be effective for COVID-19, multiple different antivirals have been examined based
… have represented an immediate and safe oral therapy for COVID-19. For most of the current …

… COVID-19 will become endemic, research should focus on identifying safe, affordable, and
globally accessible oral … surrounding the novel oral antiviral therapies in COVID-19 treatment. …

… Antiviral medications are the candidate therapies for the management of COVID-19. … In this
study, EIDD-2801 was used as BID, 12 and 36 h after infection by oral gavage. Also, the effect …

… antiviral activity against COVID-19 disease, many other studies have assessed the antiviral
… against the previous generation of SARS related coronavirus, considerably SARS-Cov and …

… -changing COVID-19 drugs like Pfizer's oral antiviral Paxlovid (… 2 years after the emergence
of COVID-19, there is finally a … trial of its new oral antiviral treatment Paxlovid: hospitalisation …

… the COVID-19 exposure to symptom onset [9]. There are 3 days on average from COVID-19 …
To evaluate the impact of antiviral therapy on the transmission dynamics of COVID-19, we …

… Although clinical trials to assess the efficacy of these antivirals … clinical uses of these antivirals
against COVID-19 pandemic. … by intra-venous route or orally. Ribavirin and sofosbuvir are …

… COVID-19, a disease caused by a novel coronavirus strain called severe acute respiratory
syndrome coronavirus 2 … search for various therapeutics to combat COVID-19 infection with no …

… We randomly assigned inpatients with Covid-19 equally between one of the trial drug
regimens that was locally available and open control (up to five options, four active and the local …

… However, administering antiviral therapy to people within three days of COVID-19 is a
clinical challenge, and the trial cohort was a part of a larger group who were treated within five …